Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Kamada Ltd. (KMDA)

« Back to company index

KMDA Chatter Timeline

Stock Ticker for KMDA

Most Active Tweeters for KMDA

UserTweets
@MoMiz32096734 3
@stock_titan 1
@kevinjaybe 1
@FlashAlert_me 1
@EdgarInsider 1

Recent Tweets for KMDA

StockNewsNow @StockNewsNow
$KMDA Kamada to Announce First Quarter Ended March 31, 2021 Financial Results and Host Conference Call on May 12, 2… https://t.co/bT5hw7wrXX
May 5th 2021, 8:05pm
SmallCapsDaily @SmallCapsDaily
$KMDA Kamada to Announce First Quarter Ended March 31, 2021 Financial Results and Host Conference Call on May 12, 2… https://t.co/iOFRdrota7
May 5th 2021, 4:05pm
EdgarInsider @EdgarInsider
Filing Alert, FORM 6-K available. $KMDA #Kamada Ltd https://t.co/EVx0VVdc95
May 5th 2021, 11:05am
FlashAlert_me @FlashAlert_me
$KMDA [15s. delayed] filed form 6-K on May 05, 07:16:42 https://t.co/UIbbeFh4XU
May 5th 2021, 11:05am
kevinjaybe @kevinjaybe
$KMDA Kamada To Announce First Quarter Ended March 31, 2021 Financial Results And Host Conference Call On May 12, 2… https://t.co/4omzYc0aCZ
May 5th 2021, 11:05am
stock_titan @stock_titan
$KMDA Kamada to Announce First Quarter Ended March 31, 2021 Financial Results and Host Conference Call on May 12, 2… https://t.co/62PuZAT4OO
May 5th 2021, 11:05am
MoMiz32096734 @MoMiz32096734
@ZeContrarian7 not sure if you are aware of the ARK investment in $KMDA , definitely a good sign for me.
May 1st 2021, 6:05am
MoMiz32096734 @MoMiz32096734
ARK ISRAEL INNOVATIVE TECHNOLOGY ETF (IZRL) HOLDINGS has 984,509 shares of $KMDA.
May 1st 2021, 6:05am
MoMiz32096734 @MoMiz32096734
Among the reasons that I found to keep and hold $kmda is Cathie Wood the CEO of Ark invest holdings that increased recently
May 1st 2021, 6:05am
ChartMill @ChartMill
$KMDA's low PEG Ratio, which compensates the PE for growth, indicates a rather cheap valuation.… https://t.co/eRcdAGCmrR
April 30th 2021, 11:04am
ZeContrarian7 @ZeContrarian7
@TcsCapitalLLC Will elaborate on all my holdings tomorrow, I reloaded on $KMDA at these prices.
April 26th 2021, 8:04pm
MarcJacksonLA @MarcJacksonLA
$KMDA Kamada & Kedrion Biopharma Forge Ahead With Development of New Anti-COVID Immunoglobulin Therapy https://t.co/B4HZSZj3nc
April 20th 2021, 3:04pm
FearLessTraDeRx @FearLessTraDeRx
$KMDA Kamada And Partner Kedrion Biopharma Say Are 'Forging Ahead' With Anti-COVID Immunoglobulin Therapy
April 20th 2021, 10:04am
nk3901 @nk3901
@ZeContrarian7 any update on $kmda - I am long on this :)
April 13th 2021, 2:04am
moneymessage_ @moneymessage_
$KMDA $TAK - Kamada says amendment to Takeda deal could accelerate payments https://t.co/IrGenSCKnk
April 8th 2021, 9:04am
newsfilterio @newsfilterio
Kamada Announces Amendment to GLASSIA® License Agreement with Takeda $KMDA https://t.co/gMWntzdGpV
April 8th 2021, 8:04am
BeefEnt @BeefEnt
RT @StockNewsNow: $KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/TnJFes1N6J
April 7th 2021, 9:04pm
StockNewsNow @StockNewsNow
$KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/TnJFes1N6J
April 7th 2021, 8:04pm
MarcJacksonLA @MarcJacksonLA
$KMDA $TAK Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/iAen4e3qFg
April 7th 2021, 8:04pm
newsfilterio @newsfilterio
Kamada says amendment to Takeda deal could accelerate payments $KMDA https://t.co/JP1f9O4y6h
April 7th 2021, 8:04pm
glitchbotio @glitchbotio
RT @MarketCurrents: $KMDA $TAK - Kamada says amendment to Takeda deal could accelerate payments https://t.co/qBMDtk1E8G
April 7th 2021, 7:04pm
MarketCurrents @MarketCurrents
$KMDA $TAK - Kamada says amendment to Takeda deal could accelerate payments https://t.co/qBMDtk1E8G
April 7th 2021, 7:04pm
SmallCapsDaily @SmallCapsDaily
$KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda GlobeNewswire https://t.co/6M23AJ3neN… https://t.co/A07LKD138R
April 7th 2021, 3:04pm
MarcJacksonLA @MarcJacksonLA
$KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/iAen4e3qFg
April 7th 2021, 2:04pm
NewsQuantified @NewsQuantified
$KMDA Announces Amendment to GLASSIA® License Agreement with Takeda. Stock rockets +9.15% https://t.co/oaJsElQchk
April 7th 2021, 12:04pm
otcdynamics @otcdynamics
$KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/wyQn1kW2Cn
April 7th 2021, 11:04am
sbwcws @sbwcws
Kamada announces amendment to GLASSIA license agreement with Takeda $KMDA $TAK
April 7th 2021, 11:04am
EdgarInsider @EdgarInsider
FORM 6-K recently SEC filed. $KMDA #Kamada Ltd https://t.co/rLnpqlpKkY
April 7th 2021, 11:04am
bthefirsttoknow @bthefirsttoknow
$KMDA.TA $KMDA Kamada Announces Amendment to GLASSIA License Agreement with Takeda https://t.co/2M57NVMIkA
April 7th 2021, 11:04am
stock_titan @stock_titan
$KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/0sKICYz1wW
April 7th 2021, 11:04am
StockNewsNow @StockNewsNow
$KMDA Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globuli… https://t.co/5HGIC6Kgl8
March 31st 2021, 4:03pm
SmallCapsDaily @SmallCapsDaily
$KMDA Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globuli… https://t.co/odnqDaRJp8
March 31st 2021, 4:03pm
MarcJacksonLA @MarcJacksonLA
$KMDA Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globuli… https://t.co/txlVL6bVAy
March 31st 2021, 2:03pm
IOInvestors @IOInvestors
$KMDA +1.8% (reports Phase 1/2 anti-SARS-CoV-2 plasma-derived hyperimmune globulin treatment for COVID-19) https://t.co/9RdZ9bzCUp
March 31st 2021, 1:03pm
Gamma_Monkey @Gamma_Monkey
Kamada Reports Top-line Data Of Plasma-Derived IgG Treatment From Early-Stage COVID-19 Trial $KMDA https://t.co/GmMNtF8I0o via @benzinga
March 31st 2021, 12:03pm
James__BondOO7 @James__BondOO7
$KMDA results from a phase 1/2 study of its plasma-derived investigational treatment for COVID-19 has shown that t… https://t.co/gBVZpt39gn
March 31st 2021, 12:03pm
FearLessTraDeRx @FearLessTraDeRx
$KMDA Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globul… https://t.co/ZuqivTQMiz
March 31st 2021, 10:03am
newsfilterio @newsfilterio
Kamada reports top-line results from mid-stage IgG trial in COVID-19 $KMDA https://t.co/mLODD8IMtn
March 31st 2021, 10:03am
Luckinvest17 @Luckinvest17
$KMDA Kamada Announces Top-line Results From Phase 1/2 Clinical Trial Of Plasma-Derived Hyperimmune Globulin Treatment For COVID-19
March 31st 2021, 10:03am
EdgarInsider @EdgarInsider
Filing for 6-K has been made with the SEC: $KMDA #Kamada Ltd https://t.co/l3Tn8IS7l5
March 31st 2021, 10:03am
Beeken_health @Beeken_health
$KMDA - Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globu… https://t.co/kwefW270nE
March 31st 2021, 10:03am
StckPro @StckPro
$KMDA NEW ARTICLE : Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyper… https://t.co/9guYWSuOFN
March 31st 2021, 10:03am
stock_titan @stock_titan
$KMDA Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globuli… https://t.co/I9DYfBBZL4
March 31st 2021, 10:03am
MarcJacksonLA @MarcJacksonLA
$KMDA Kamada to Present at the Jefferies Global Plasma Summit https://t.co/8db6TAGk8K
March 9th 2021, 4:03pm
SmallCapsDaily @SmallCapsDaily
$KMDA Kamada to Present at the Jefferies Global Plasma Summit GlobeNewswire https://t.co/l9UuEcgH7J #smallcapsdaily… https://t.co/Tie1BupuOn
March 9th 2021, 4:03pm
StckPro @StckPro
$KMDA NEW ARTICLE : Kamada to Present at the Jefferies Global Plasma Summit https://t.co/2EH8hvRFJg Get all the lat… https://t.co/Ve909KpCOC
March 9th 2021, 12:03pm
EdgarInsider @EdgarInsider
Filing for 6-K has been made with the SEC: $KMDA #Kamada Ltd https://t.co/nohQJXhxm1
March 9th 2021, 12:03pm
FlashAlert_me @FlashAlert_me
$KMDA [15s. delayed] filed form 6-K on March 09, 07:00:09 https://t.co/lofxps9jKP
March 9th 2021, 12:03pm
StockNewsNow @StockNewsNow
$KMDA Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and P… https://t.co/VCvs207e2L
March 3rd 2021, 7:03pm
MarcJacksonLA @MarcJacksonLA
$KMDA Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and P… https://t.co/ERQbxIhxaL
March 3rd 2021, 4:03pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.